Myocardial Extracellular and Cardiomyocyte Volume Expand After Doxorubicin Treatment Similar to Adjuvant Breast Cancer Therapy

Autor:	Sujethra Vasu, Susan E. Appt, Edward J. Lesnefsky, Jennifer H. Jordan, Jay R. Kaplan, Ralph B. D'Agostino, Giselle C. Meléndez, W. Gregory Hundley
Rok vydání:	2020
Předmět:	Anthracycline medicine.medical_treatment Breast Neoplasms 030204 cardiovascular system & hematology Ventricular Function Left Article 030218 nuclear medicine & medical imaging Ventricular Dysfunction Left 03 medical and health sciences 0302 clinical medicine Text mining Breast cancer Predictive Value of Tests Chlorocebus aethiops Extracellular medicine Animals Myocytes Cardiac Radiology Nuclear Medicine and imaging Doxorubicin Cell Size Chemotherapy Antibiotics Antineoplastic Ventricular Remodeling business.industry medicine.disease Fibrosis Magnetic Resonance Imaging Cardiotoxicity Chemotherapy Adjuvant cardiovascular system Cancer research Female Hypertrophy Left Ventricular Cardiology and Cardiovascular Medicine business Adjuvant medicine.drug Volume (compression)
Zdroj:	JACC Cardiovasc Imaging
ISSN:	1936-878X
DOI:	10.1016/j.jcmg.2019.10.020
Popis:	Increased left ventricular (LV) myocardial extracellular volume fraction (ECVF) measured by cardiac magnetic resonance (CMR) is now a recognized consequence of anthracycline chemotherapy ([1][1],[2][2]). It remains unknown, however, whether elevated ECVF may be attributable to an expansion of the LV
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36ad15ad34e517ad0572e83f741fcd15 https://doi.org/10.1016/j.jcmg.2019.10.020 Zobrazit plný text záznamu